Skip to main content
BioCardia, Inc. logo

BioCardia, Inc. — Investor Relations & Filings

Ticker · BCDA ISIN · US09060U5074 LEI · 5493003EDBXRQRW22O75 US Manufacturing
Open in API
Filings indexed 1,023 across all filing types
Latest filing 2018-04-27 Proxy Solicitation & In…
Country US United States of America
Listing US BCDA

About BioCardia, Inc.

https://www.biocardia.com/

BioCardia, Inc. is a clinical-stage regenerative medicine company that develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. The company's lead program is the CardiAMP® cell therapy system, an autologous therapy that uses a patient's own bone marrow cells to potentially stimulate the body's natural healing response in the heart. This therapy is primarily being evaluated for the treatment of ischemic heart failure. In addition to its autologous platform, BioCardia is also developing CardiALLO™, an allogeneic cell therapy platform using cells from qualified donors. The company's approach integrates biotherapeutic candidates with proprietary delivery systems for targeted administration.

Recent filings

Filing Released Lang Actions
FORM DEF 14A
Proxy Solicitation & Information Statement
2018-04-27 English
FORM 4
Director's Dealing
2018-04-20 English
FORM S-8
Capital/Financing Update Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC by BioCardia, Inc. It registers additional shares of common stock under the company's 2016 Equity Incentive Plan. The document includes details about the number of shares, the plan's evergreen provision, and references to prior filings. It is a registration statement for securities issuance under an employee benefit plan, not a financial report, earnings release, or management discussion. Form S-8 is a specific SEC filing used to register securities to be offered to employees under stock plans. This matches the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including registration of shares for equity incentive plans.
2018-04-20 English
FORM 4
Director's Dealing
2018-03-26 English
FORM 4
Director's Dealing
2018-03-22 English
FORM 4
Director's Dealing
2018-03-22 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.